SHILPA MEDICARE
Quarterly Results Analysis [Dec2024]
SHILPA MEDICARE Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹319 Cr | ₹344 Cr | ₹293 Cr | ₹292 Cr | ₹287 Cr | ₹313 Cr | ₹260 Cr | ₹264 Cr |
Expenses | ₹239 Cr | ₹258 Cr | ₹219 Cr | ₹222 Cr | ₹221 Cr | ₹253 Cr | ₹212 Cr | ₹225 Cr |
Operating Income | ₹81 Cr | ₹86 Cr | ₹74 Cr | ₹70 Cr | ₹66 Cr | ₹60 Cr | ₹48 Cr | ₹38 Cr |
Other Income | ₹1 Cr | ₹5 Cr | ₹9 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Interest | ₹12 Cr | ₹26 Cr | ₹24 Cr | ₹24 Cr | ₹26 Cr | ₹23 Cr | ₹18 Cr | ₹18 Cr |
Depreciation | ₹29 Cr | ₹28 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹28 Cr | ₹27 Cr | ₹26 Cr |
Profit Before Tax | ₹41 Cr | ₹37 Cr | ₹32 Cr | ₹28 Cr | ₹15 Cr | ₹11 Cr | ₹5 Cr | ₹-3 Cr |
Profit After Tax | ₹31 Cr | ₹18 Cr | ₹18 Cr | ₹25 Cr | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹-7 Cr |
EPS | ₹3.25 | ₹1.83 | ₹1.44 | ₹2.82 | ₹0.53 | ₹0.19 | ₹0.14 | ₹-0.93 |
Industry Peers & Returns | 1W | 1M | 1Y |
SHILPA MEDICARE | -5% | 1% | 34.4% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
CIPLA | -1.8% | 1% | 0.5% |
TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
LUPIN | -2.7% | 1% | 30.1% |
SHILPA MEDICARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -7.12 % |
Y-o-Y | 11.35 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹319 Cr | -7.12 | |
Sep2024 | ₹344 Cr | 17.53 | |
Jun2024 | ₹293 Cr | 0.28 | |
Mar2024 | ₹292 Cr | 1.72 | |
Dec2023 | ₹287 Cr | -8.38 | |
Sep2023 | ₹313 Cr | 20.29 | |
Jun2023 | ₹260 Cr | -1.29 | |
Mar2023 | ₹264 Cr | - |
SHILPA MEDICARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -6.18 % |
Y-o-Y | 21.84 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹81 Cr | -6.18 | |
Sep2024 | ₹86 Cr | 16.86 | |
Jun2024 | ₹74 Cr | 5.05 | |
Mar2024 | ₹70 Cr | 5.78 | |
Dec2023 | ₹66 Cr | 9.83 | |
Sep2023 | ₹60 Cr | 25.83 | |
Jun2023 | ₹48 Cr | 25.36 | |
Mar2023 | ₹38 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 1.00 % |
Y-o-Y | 9.39 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 25.27% | 1.00 | |
Sep2024 | 25.02% | -0.56 | |
Jun2024 | 25.16% | 4.75 | |
Mar2024 | 24.02% | 3.98 | |
Dec2023 | 23.1% | 19.88 | |
Sep2023 | 19.27% | 4.61 | |
Jun2023 | 18.42% | 27.03 | |
Mar2023 | 14.5% | - |
SHILPA MEDICARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 71.51 % |
Y-o-Y | 445.13 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹31 Cr | 71.51 | |
Sep2024 | ₹18 Cr | 4.28 | |
Jun2024 | ₹18 Cr | -28.66 | |
Mar2024 | ₹25 Cr | 327.24 | |
Dec2023 | ₹6 Cr | 65.70 | |
Sep2023 | ₹3 Cr | 22.61 | |
Jun2023 | ₹3 Cr | Positive | |
Mar2023 | ₹-7 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 84.80 % |
Y-o-Y | 390.05 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 9.85 % | 84.80 | |
Sep2024 | 5.33 % | -11.31 | |
Jun2024 | 6.01 % | -28.88 | |
Mar2024 | 8.45 % | 320.40 | |
Dec2023 | 2.01 % | 81.08 | |
Sep2023 | 1.11 % | 1.83 | |
Jun2023 | 1.09 % | Positive | |
Mar2023 | -2.6 % | - |
SHILPA MEDICARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 77.60 % |
Y-o-Y | 513.21 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹3.25 | 77.60 | |
Sep2024 | ₹1.83 | 27.08 | |
Jun2024 | ₹1.44 | -48.94 | |
Mar2024 | ₹2.82 | 432.08 | |
Dec2023 | ₹0.53 | 178.95 | |
Sep2023 | ₹0.19 | 35.71 | |
Jun2023 | ₹0.14 | Positive | |
Mar2023 | ₹-0.93 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD